7/1/2022Solasia to Slash 65% of Workforce in China as It Transfers Core Distri...

6/23/2022Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...

6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...

6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021

6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031

5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021

5/26/2022Ten Trends of China's Pharmaceutical Industry in 2021 (PharmCube)

5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021

5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...

5/13/2022Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2021

5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...

5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021

5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021

5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...

4/29/2022Adagene-Sanofi's $2.5B Deal Tops March Deals in China (PharmaDJ)

4/28/2022Sales Expenditures of Listed Chinese Pharma Companies Sharply Up Again...

4/28/2022SMEI Revises Down Chinese Pharma Industry Growth Projection in 2022

4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

4/11/2022Clinical Development Strategies for Western Biotech Companies in China...

4/10/2022Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021

4/10/2022Chinese Pharma Profits Fell Sharply in the First Two Months of 2022

3/30/2022IQVIA: Chinese Biopharma Investment Hotspots and Sustainability

3/21/2022As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...

3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)

3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...

3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)

2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...

2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021

2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...

Page:5/22 Total number of articles:640: [First][<<] [3] [4] [5] [6] [7] [>>] [End]